spacer
home > ebr > media info
MEDIA INFORMATION









WHY ADVERTISE?






EBR is well-established industry voice, providing an advertising platform to companies from across the biotech sector. Its targeted circulation to key global decision makers guarantees maximum exposure for your company. Furthermore, EBR’s media partnerships with key industry events provide advertisers with bonus distribution opportunities throughout the year.

EBR’s presence online offers exciting digital opportunities.
With a comprehensive company directory, and press releases
and events listing facilities, the website is the ideal platform to showcase banners and logos. The website is complemented by
the magazine’s ebook – an interactive digital edition of EBR
that opens up a whole host of rich media advertising options.





 
   




READERSHIP: JOB FUNCTIONS





Business Development 
Clinical Research
Corporate Management
Industry Consultancy
Laboratory
Manufacturing


 

Marketing and Sales
Preclinical/Clinical Trials
Product Development
Project Management
QA/QC
R&D







   














 

   




ADVERTISING RATES


 

WEB SITE FACILITIES





SIZE
RATE
FRONT COVER LOGO 
 £1,500
DOUBLE PAGE SPREAD
£4,550
SINGLE PAGE
£2,850
HALF PAGE
£1,575
QUARTER PAGE
£895
OPPOSITE CONTENT PAGES
£3,750
OPPOSITE EDITOR’S LETTER
£3,750
INSIDE FRONT COVER
£5,950
INSIDE BACK COVER
£3,450
OUTSIDE BACK COVER
£6,750

 

1) Hyperlink from a relevant section of our website to client website
2) Banner and/or logo on
our website (see below for
banner specifications)
3) Client news page – to use for press releases during the duration
of advertising.
4) Corporate profile up to 350 words

Banner Specifications 
GIF or JPEG (if static) or SWF (flash), 468x60 or 200x150 pixels.





 
   




REPROGRAPHIC MECHANICAL SPECIFICATIONS





MECHANICAL DETAILS (IN MM)





Type Size
Trim Size
Bleed Size

Double Page*

273 x 396
297 x 420
303 x 426

One Page

273 x 186
297 x 210
303 x 213

1/2 page (horizontal)

135 x 186
148 x 210
151 x 213

1/2 page (vertical)

273 x 92
297 x 105
303 x 108

1/4 page

135 x 92
N/A
N/A





Electronic pictures or graphics can be supplied in the following formats:

1. Adobe Photoshop CS2 TIFF (*.tif), JPEG, PSD or EPS
2. Adobe Illustrator CS2 EPS

Electronic images/graphics must be supplied at high resolution
(at least 300dpi)
Electronic images/graphics should be in CMYK colour.
Please do not send picture files embedded in Microsoft
Word documents.
Please supply them as separate attachments.

Pictures can be supplied as good quality colour or black and
white photographs

Client designed adverts should be supplied in one of the following ways:

1. QuarkXpress 6 (not Quark Passport) - Relevant high-resolution graphics and fonts must also be supplied.

2. Adobe Illustrator CS2 - Images and graphics must be
embedded. Fonts should be supplied if they are not embedded/converted to outline.

3. Adobe Acrobat PDF - Advert PDFs must be supplied optimised
for high-quality printing. All colours (including pictures) must be
CMYK, and not RGB or Pantone. Graphics must be high resolution (300dpi), with all fonts embedded. Bleed adverts must include registration markings and bleed. We are unable to make ammendments to PDF files.

All adverts should be supplied with a colour copy of the advert.
PDFs are supplied entirely at the client’s own risk and the publisher accepts no responsibility for any errors in printing. Electronic files
can be emailed to us. Larger files (above 10Mb) should be supplied
to us on CD.

spacer
Edited by
Dr Deborah O'Neil,
Chief Executive and Scientific Officer,
NovaBiotics Ltd
Published quarterly in
January, April,
July, and October
 
Industry Events

Synthetic Biology Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies.
More info >>

 
News and Press Releases

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

Philadelphia, PA & Auburn, AL – September 17, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce its exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-BlisterTM packaging solutions, which help protect and promote speed-to-market for pharmaceutical and medical device products with heightened susceptibility to moisture and gases, especially oxygen.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement